Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
about
Hybrid approach for predicting coreceptor used by HIV-1 from its V3 loop amino acid sequenceHIV-1 induced bystander apoptosisTenascin-C is an innate broad-spectrum, HIV-1-neutralizing protein in breast milkHIV: cell binding and entryClinical significance of HIV-1 coreceptor usage.HIV-1 subtype D infections among Caucasians from Northwestern Poland--phylogenetic and clinical analysisReconstructing the Dynamics of HIV Evolution within Hosts from Serial Deep Sequence DataDefining the fitness of HIV-1 isolates with dual/mixed co-receptor usageHIV-1 Genetic Variability and Clinical ImplicationsReliable genotypic tropism tests for the major HIV-1 subtypesAppreciating HIV type 1 diversity: subtype differences in Env.Identification of new splice sites used for generation of rev transcripts in human immunodeficiency virus type 1 subtype C primary isolates.Different tempo and anatomic location of dual-tropic and X4 virus emergence in a model of R5 simian-human immunodeficiency virus infection.Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individualsFrequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West AfricaConstrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry.HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children.Detection of inferred CCR5- and CXCR4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing.Distinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist.Clustering of HIV-1 Subtypes Based on gp120 V3 Loop electrostatic propertiesVariation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis.Low frequency of CXCR4-using viruses in patients at the time of primary non-subtype-B HIV-1 infectionCo-receptor usage and prediction of V3 genotyping algorithms in HIV-1 subtype B' from paid blood donors experienced anti-retroviral therapy in Chinese central province.Appraising the performance of genotyping tools in the prediction of coreceptor tropism in HIV-1 subtype C virusesHigh prevalence of CXCR4 usage among treatment-naive CRF01_AE and CRF51_01B-infected HIV-1 subjects in Singapore.The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort studyRisk of breast cancer with CXCR4-using HIV defined by V3 loop sequencingAnalysis of HIV tropism in Ugandan infants.A case-based reasoning system for genotypic prediction of HIV-1 co-receptor tropism.Effect of HIV-1 subtypes on disease progression in rural Uganda: a prospective clinical cohort study.A diagnostic HIV-1 tropism system based on sequence relatedness.Clinical use of CCR5 inhibitors in HIV and beyondSelected amino acid mutations in HIV-1 B subtype gp41 are associated with specific gp120v₃ signatures in the regulation of co-receptor usage.V3-independent competitive resistance of a dual-X4 HIV-1 to the CXCR4 inhibitor AMD3100CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa.Alterations in HIV-1 gp120 V3 region are necessary but not sufficient for coreceptor switching in CRF07_BC in China.Genotypic prediction of HIV-1 subtype D tropismCCR5: From Natural Resistance to a New Anti-HIV Strategy.Efficiency of CCR5 coreceptor utilization by the HIV quasispecies increases over time, but is not associated with disease progression.The epidemiology and clinical correlates of HIV-1 co-receptor tropism in non-subtype B infections from India, Uganda and South Africa.
P2860
Q21559666-8AECE2A0-FCA7-4340-A75C-B01333166DE9Q22241221-E3DD8A48-E16E-49B3-BB68-663AA0672052Q24598653-058F0CED-C36B-4227-9B6B-6799F57B0EC4Q27008983-FF4620A5-E01F-4918-81C9-EB0EB3C3DC24Q27691426-4070C67D-9560-407E-80C4-943C2FA4D53AQ28480877-09BD1587-853F-4F90-9AF4-E4D2FAD1C0FEQ29394572-4BAD3375-D4D3-49DC-86D9-831639597229Q30278577-6D4C8297-A8E4-4A0A-85BF-0D872FC8FA69Q30352010-99DDDB5A-F178-4FCC-8C06-283C12BD1B5DQ30372085-DA8CD74D-2867-4045-943D-4A3490B2220BQ30375834-8C5D7F69-12DA-4D0B-8FAB-AAFC44EE9077Q30413474-2D608012-3D3D-46CE-A966-1AB82CDCE028Q33558676-A7FDEB61-2F27-48F9-9741-8A7BB867A898Q33685141-912722FE-F6A6-4679-92F2-26B11A65E219Q33793066-77E88A13-C0C1-4679-A538-7C4CF7B12F72Q33857491-8B3C4883-C28E-4D8A-8DC4-CAF900BF3F54Q33893123-F69A4049-71C0-42BF-8F68-4B9D0D86CC93Q33951977-FCF75A58-5E1E-4C57-AABD-1039AABD99F6Q34055508-C75D03F1-DEF8-4122-A074-1563FDA600C3Q34153074-ABDD032A-B00A-436C-A08F-948D1D747080Q34170655-6E412F89-11E4-4200-B430-3E31A69B8B93Q34190296-04494DC2-A7B7-4C46-9C8E-D9F65326C0A4Q34332104-9674F726-EFD3-4D11-91B7-D48BF5BD9137Q34400487-5E0E1496-6B70-48DE-8A08-51BAF513C87CQ34591699-1D69ADEA-299E-4066-859B-5EB8FA892F3AQ34609382-B8E25DDA-CB78-4310-BCD9-84543F4EFCD8Q34674367-05BC085C-63B3-4DC2-AA93-6B6DCEFB9D4CQ34786687-590001F6-8B25-4ACD-AB9F-4D12E23ABA81Q34823507-50B9A0BC-C4D2-46A1-9B73-BBDDCBD2B2B5Q34950563-A69CF1FB-9178-4D8C-A156-CD10A9EE5199Q34983107-ED1DC40B-C45B-4B52-B229-BC9EBD529554Q35018145-D09C3B5E-45A4-4D2C-A813-135B2AC99AB2Q35052934-A8037D07-1ABC-41D5-9825-A63064E53F0FQ35107518-562E2ABF-C1E0-405D-A956-4BA8129F8605Q35119369-9C68EF93-1DB6-4733-9A32-160FD91ED93AQ35133895-10094E8A-4840-4DAB-A12D-1E7608A68011Q35137552-98747D16-8018-4418-B64C-99D333E29C14Q35260605-056FD79E-A4B0-4283-8C5B-DB56B935AAD3Q35799147-B19D07D7-10CE-4B6D-98F4-9277C68190EDQ35818419-44126A3F-CB5F-442B-8FC3-F4665E804DBD
P2860
Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Coreceptor tropism in human im ...... position of viral populations.
@ast
Coreceptor tropism in human im ...... position of viral populations.
@en
type
label
Coreceptor tropism in human im ...... position of viral populations.
@ast
Coreceptor tropism in human im ...... position of viral populations.
@en
prefLabel
Coreceptor tropism in human im ...... position of viral populations.
@ast
Coreceptor tropism in human im ...... position of viral populations.
@en
P2093
P2860
P50
P356
P1433
P1476
Coreceptor tropism in human im ...... mposition of viral populations
@en
P2093
Alicia M Young
Ellen E Paxinos
Eric Stawiski
Francis Mmiro
Jeannette M Whitcomb
Laura A Guay
Neil T Parkin
Philippa Musoke
Signe Fransen
P2860
P304
P356
10.1128/JVI.00218-07
P407
P577
2007-05-16T00:00:00Z